InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Shiff Susan Ph.D., Director. Officer active across 1 company, notably Cara Therapeutics, Inc.. In total, 5 reports have been logged. History available since 3 June 2021. The latest transaction was filed on 4 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
150,647 shares0Common StockSEC:0001415889-24-015756:0
32,362 shares0Common StockSEC:0001209191-23-034330:0
11,876 shares0Common StockSEC:0001209191-22-034627:0
7,200 shares0Common StockSEC:0001209191-21-038765:0
7,200 shares0Common StockSEC:0001209191-21-038765
5 of 5 declarations
About Shiff Susan Ph.D.
Susan Ph.D. Shiff is a Board Member of Cara Therapeutics, Inc. She brings expertise in research and development in the pharmaceutical field. Her role involves overseeing the company's research initiatives, which focus on pain management treatments.
